These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4355038)

  • 41. Effects of catecholamines, exercise, and nitroglycerin on the normal and ischemic myocardium in conscious dogs.
    Vatner SF; McRitchie RJ; Maroko PR; Patrick TA; Braunwald E
    J Clin Invest; 1974 Sep; 54(3):563-75. PubMed ID: 4152859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of trapidil and nitroglycerin on coronary circulation in conscious dogs.
    Noguchi K; Tomoike H; Kawachi Y; Nabeyama S; Shimokawa H; Maruoka Y; Nakamura M
    Arzneimittelforschung; 1984; 34(8):872-6. PubMed ID: 6437414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
    Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction of ischemic injury by nitroglycerin during acute myocardial infarction.
    Epstein SE; Kent KM; Goldstein RE; Borer JS; Redwood DR
    N Engl J Med; 1975 Jan; 292(1):29-35. PubMed ID: 803223
    [No Abstract]   [Full Text] [Related]  

  • 45. Coronary vascular responses to vasodilator drugs.
    Goldstein RE
    Prog Cardiovasc Dis; 1982; 24(6):419-36. PubMed ID: 6210936
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of a decrease in perfusion pressure on the alpha-adrenergic reactions of the coronary vessels].
    Novikova EB; Serebriakova LI; Tskitishvili OV
    Kardiologiia; 1988 Aug; 28(8):79-82. PubMed ID: 2848968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo.
    Münzel T; Bassenge E
    Circulation; 1996 Jun; 93(11):2052-8. PubMed ID: 8640982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alteration of vasopressin tachyphylaxis by reserpine pretreatment.
    Nash CB
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):90-5. PubMed ID: 5834943
    [No Abstract]   [Full Text] [Related]  

  • 49. [Action of Persantin and nitroglycerin on systemic and coronary hemodynamics in the dog. Preliminary note].
    Pandolfo G; Uslenghi E; Dessy P; Gagna C; Brocchi G; Giannini R; Campus S
    Minerva Cardioangiol; 1970 Oct; 18(10):589-93. PubMed ID: 4993306
    [No Abstract]   [Full Text] [Related]  

  • 50. Influence of arterial oxygen tension on coronary vasodilator action of nitroglycerine.
    Cronin RF; Kovacs A
    Can J Physiol Pharmacol; 1969 Jan; 47(1):93-8. PubMed ID: 4973481
    [No Abstract]   [Full Text] [Related]  

  • 51. Is the cardiovascular effect of nitroglycerin related to the prostaglandin system in the dog?
    Sakai K; Akima M; Nakamura Y
    Eur J Pharmacol; 1983 Dec; 96(3-4):285-9. PubMed ID: 6426977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha adrenergic constriction of coronary arteries in conscious dogs.
    Vatner SF; Pagani M; Manders WT
    Trans Assoc Am Physicians; 1979; 92():229-38. PubMed ID: 232943
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of nitroglycerin and dipyridamole on regional left ventricular blood flow during coronary artery occlusion.
    Becker LC
    J Clin Invest; 1976 Dec; 58(6):1287-96. PubMed ID: 825534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary and secondary effects of angiotensin on the coronary circulation.
    Drímal J; Pávek K; Selecký FV
    Cardiologia (Basel); 1969; 54(1):1-15. PubMed ID: 4313476
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of nitroglycerin on the ventricular function, coronary circulation and oxygen consumption of the left ventricle under constant arterial pressure and heart rate].
    Strauer BE; Höfling B; Scherpe A
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1126-8. PubMed ID: 829459
    [No Abstract]   [Full Text] [Related]  

  • 56. Understanding the coronary circulation through studies at the microvascular level.
    Marcus ML; Chilian WM; Kanatsuka H; Dellsperger KC; Eastham CL; Lamping KG
    Circulation; 1990 Jul; 82(1):1-7. PubMed ID: 2114232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic vasodilators in the coronary circulation.
    Schwartz JS; Bache RJ
    Circulation; 1987 Jan; 75(1 Pt 2):I162-7. PubMed ID: 3791617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of plasma from hypertensive patients on the responses to angiotensin and norepinephrine in dogs and rats.
    Greenberg S; Boldstein B; Wilson WR
    Clin Pharmacol Ther; 1974 Apr; 15(4):337-43. PubMed ID: 4362506
    [No Abstract]   [Full Text] [Related]  

  • 59. [Physiology of the coronary circulation as a basis for evaluating coronary dilators].
    Lochner W
    Kardiologiia; 1972 Jan; 12(1):22-31. PubMed ID: 4622744
    [No Abstract]   [Full Text] [Related]  

  • 60. ITF 296, a new endothelium-independent vasodilator: comparison with nitroglycerin and isosorbide dinitrate.
    Ghaleh B; Dubois-Randé JL; Hittinger L; Berdeaux A; Giudicelli JF
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S6-12. PubMed ID: 8839220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.